---
title: Identifying subgroups with differential response to CBASP versus Escitalopram
  during the first eight weeks of treatment in outpatients with persistent depressive
  disorder
date: '2023-08-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37606728/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230822180916&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: There exists little empirical evidence helping clinicians to select the
  most effective treatment for individual patients with persistent depressive disorder
  (PDD). This study identifies and characterizes subgroups of patients with PDD who
  are likely to benefit more from an acute treatment with psychotherapy than from
  pharmacotherapy and vice versa. Non-medicated outpatients with PDD were randomized
  to eight weeks of acute treatment with the Cognitive Behavioral Analysis System
  of ...
disable_comments: true
---
There exists little empirical evidence helping clinicians to select the most effective treatment for individual patients with persistent depressive disorder (PDD). This study identifies and characterizes subgroups of patients with PDD who are likely to benefit more from an acute treatment with psychotherapy than from pharmacotherapy and vice versa. Non-medicated outpatients with PDD were randomized to eight weeks of acute treatment with the Cognitive Behavioral Analysis System of ...